ATE281521T1 - Von filaggrin abgeleitete antigene und deren anwendung in der diagnose von rheumatischer polyarthritis - Google Patents

Von filaggrin abgeleitete antigene und deren anwendung in der diagnose von rheumatischer polyarthritis

Info

Publication number
ATE281521T1
ATE281521T1 AT97938965T AT97938965T ATE281521T1 AT E281521 T1 ATE281521 T1 AT E281521T1 AT 97938965 T AT97938965 T AT 97938965T AT 97938965 T AT97938965 T AT 97938965T AT E281521 T1 ATE281521 T1 AT E281521T1
Authority
AT
Austria
Prior art keywords
filaggrin
diagnosis
application
derived antigens
polyarthritis
Prior art date
Application number
AT97938965T
Other languages
English (en)
Inventor
Guy Serre
Elisabeth Girbal-Neuhauser
Christian Vincent
Michel Simon
Mireille Sebbag
Pascal Dalbon
Colette Jolivet-Reynaud
Michel Arnaud
Michel Jolivet
Original Assignee
Biomerieux Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9495335&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE281521(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biomerieux Sa filed Critical Biomerieux Sa
Application granted granted Critical
Publication of ATE281521T1 publication Critical patent/ATE281521T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
AT97938965T 1996-08-30 1997-09-01 Von filaggrin abgeleitete antigene und deren anwendung in der diagnose von rheumatischer polyarthritis ATE281521T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9610651A FR2752842B1 (fr) 1996-08-30 1996-08-30 Antigenes derives des filaggrines et leur utilisation pour le diagnostic de la polyarthrite rhumatoide
PCT/FR1997/001541 WO1998008946A1 (fr) 1996-08-30 1997-09-01 Antigenes derives des filaggrines et leur utilisation pour le diagnostic de la polyarthrite rhumatoide

Publications (1)

Publication Number Publication Date
ATE281521T1 true ATE281521T1 (de) 2004-11-15

Family

ID=9495335

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97938965T ATE281521T1 (de) 1996-08-30 1997-09-01 Von filaggrin abgeleitete antigene und deren anwendung in der diagnose von rheumatischer polyarthritis

Country Status (9)

Country Link
US (1) US6890720B1 (de)
EP (2) EP0929669B1 (de)
AT (1) ATE281521T1 (de)
CA (1) CA2264019C (de)
DE (1) DE69731479T2 (de)
ES (1) ES2227711T3 (de)
FR (1) FR2752842B1 (de)
PT (1) PT929669E (de)
WO (1) WO1998008946A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1004539C2 (nl) * 1996-11-15 1998-05-20 Stichting Tech Wetenschapp Peptide afgeleid van een door auto-antilichamen van patiënten met reumatoïde artritis herkend antigeen, antilichaam daartegen en werkwijze voor het detecteren van auto-immuunantilichamen.
WO1999028344A2 (en) * 1997-11-28 1999-06-10 Innogenetics N.V. Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
EP0949270A1 (de) * 1998-04-09 1999-10-13 Innogenetics N.V. Citrullin-enthaltende synthetische Peptide, reaktiv mit Seren von Patienten mit rheumatische Arthritis, zur Diagnose und Behandlung
FR2773078B1 (fr) * 1997-12-30 2000-05-26 Univ Toulouse Utilisation de peptides citrullines derives de la filaggrine pour le traitement de la polyarthrite rhumatoide
FR2773157B1 (fr) * 1997-12-30 2001-10-05 Bio Merieux Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide
DE1240180T1 (de) * 1999-12-21 2003-08-14 Innogenetics Nv Peptide zur diagnose und behandlung rheumatischer arthritis
FR2826124B1 (fr) * 2001-06-13 2004-01-02 Bio Merieux Procede de detection d'auto-anticorps specifiques de la polyarthrite rhumatoide
NL1019540C2 (nl) * 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Werkwijze voor het detecteren van auto-antilichamen van patienten die lijden aan reumatoïde artritis, peptide en assaykit.
DE602004025636D1 (de) 2003-12-23 2010-04-01 Roche Diagnostics Gmbh Methode zur Beurteilung von rheumatoider Arthritis durch Bestimmung von Anti-CCP und Interleukin 6
DK1721162T3 (da) 2004-02-27 2008-12-15 Hoffmann La Roche Fremgangsmåde til at bedömme rheumatoid arthritis ved at måle anti-CCP og serumamyloid A
US20060141547A1 (en) * 2004-11-16 2006-06-29 Das Hasi R Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis
WO2006106823A1 (ja) * 2005-03-31 2006-10-12 Japan Science And Technology Agency 分子マーカーを用いた間葉系幹細胞の識別方法及びその利用
US7362443B2 (en) * 2005-11-17 2008-04-22 Honeywell International Inc. Optical gyro with free space resonator and method for sensing inertial rotation rate
EP2074428B1 (de) 2006-09-29 2015-07-01 Roche Diagnostics GmbH Beurteilung des risikos eines fortschreitens der krankheit bei einem patienten mit rheumatoider arthritis
EP2325195A1 (de) 2009-11-23 2011-05-25 Toscana Biomarkers S.r.l. Virale citrullinierte Peptide und Verwendungen dafür
EP2336769A1 (de) 2009-12-18 2011-06-22 F. Hoffmann-La Roche AG Assay zur Unterscheidung zwischen rheumatischen und nicht rheumatischen Leiden
EP2402368A1 (de) 2010-07-02 2012-01-04 Toscana Biomarkers S.r.l. Histoncitrullinierte Peptide und deren Verwendungen
EP2527841A1 (de) 2011-05-25 2012-11-28 Toscana Biomarkers S.r.l. Verfahren zur Diagnose rheumatoider Arthritis
EP3056904A1 (de) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Verfahren zur Beurteilung rheumatoider Arthritis mittels Messung von Anti-CCP und Anti-MCM3
EP3056903A1 (de) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Verfahren zur Beurteilung rheumatoider Arthritis mittels Messung von Anti-CCP und Anti-Casp8
CN107484423A (zh) 2015-02-13 2017-12-15 豪夫迈·罗氏有限公司 通过测量抗ccp和抗pik3cd来评估类风湿性关节炎的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATA38988A (de) * 1988-02-18 1993-11-15 Josef Dr Smolen Verfahren zur untersuchung menschlicher oder tierischer körperflüssigkeiten sowie reagens hierfür
CA2084876A1 (fr) * 1991-04-26 1992-10-27 Guy Serre Antigenes specifiquement reconnus par des anticorps specifiques de la polyarthrite rhumatoide, leurs proteines constitutives, leur preparation et leurs applications

Also Published As

Publication number Publication date
EP0929669B1 (de) 2004-11-03
EP0929669A1 (de) 1999-07-21
CA2264019A1 (fr) 1998-03-05
CA2264019C (fr) 2012-04-10
ES2227711T3 (es) 2005-04-01
FR2752842B1 (fr) 1998-11-06
US6890720B1 (en) 2005-05-10
DE69731479D1 (de) 2004-12-09
EP1475438A1 (de) 2004-11-10
PT929669E (pt) 2005-01-31
WO1998008946A1 (fr) 1998-03-05
DE69731479T2 (de) 2006-02-02
FR2752842A1 (fr) 1998-03-06

Similar Documents

Publication Publication Date Title
ATE281521T1 (de) Von filaggrin abgeleitete antigene und deren anwendung in der diagnose von rheumatischer polyarthritis
CA2124953A1 (en) Peptides related to prion proteins
ATE130855T1 (de) Antikörper gegen latente proteine von menschlichen papillomavirus, diagnostische systeme und methoden.
LU91013I2 (fr) ReFacto (Moroctocog alfa) dans toutes ses formes couvertes par le brevet de base
DE69725739D1 (de) Meningokokkus b-epitop ausbildende monoklonale antikoerper und deren verwendung zur herstellung von impfstoffzusammenstellungen
TR200003181T2 (tr) Gelişmiş çoğaltılabilirliğe sahip FAP alfa'ya özgü antikor
DE69322860D1 (de) Antikörper gegen alpha v beta 3 integrin
DK228190D0 (da) Rajgraespollenallergen
DE3788397T2 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
AU2042992A (en) Seroreactive regions on hpv 16 proteins e1 and e2
DE69531958D1 (de) (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper
ATE310019T1 (de) Citrullin-enthaltende fibrin-derivate und ihre verwendung zur diagnose und behandlung von rheumatischer arthritis
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
ATE397659T1 (de) Polyklonale antikörper gegen den menschlichen alpha-pdgf-rezeptor und dessen verwendung
DE69529272D1 (de) MONOKLONALER ANTIKÖRPER GEGEN DAS HUMANE Mx-PROTEIN MxA
SE8900899D0 (sv) Peptides for diagnostic use
CA2088354A1 (en) Pancreas-Elastasis-1-Specific Antibody, a Process for Obtaining It and a Test Kit Containing Such Antibodies
DE3688204T2 (de) Monoklonaler antikoerper gegen ein p21-bezuegliches dodekapeptid des ras-onkogens.
FI913714A (fi) Peptider med foer a 1-mikroglobulin karakteristiska antigeniska determinanter.
EP0412970A4 (en) Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein
DE3686766T2 (de) Monoklonaler antikoerper gegen glutathion s-transferase und dessen verwendung zur diagnose von krebs.
EA200001252A1 (ru) КОМПОЗИЦИЯ РЕКОМБИНАНТНОГО ИНТЕРФЕРОНА-β-1A(IFN-β-1A) ЧЕЛОВЕКА
FI86255B (fi) Monoklonal antiurokinase-antikropp, den innehaollande matris och biokemiska testpackningar, i vilka den anvaendes.
IT1241003B (it) Procedimento per la purificazione di un polipeptide ricombinante hdag equivalente, polipeptide hdag equivalente e saggi immunologici che lo utilizzano
EA199801032A1 (ru) Белки zona pellucida для контрацепции

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties